Policy & Regulation: Page 26

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Sense and Sensibility -- Pamela Williamson Joyce

    With a wide and deep understanding of the inner sanctum of numerous departments in the life sciences, Pamela Williamson Joyce has been able to bring both inventiveness and clear-headed thinking to Serono’s regulatory practice, helping the company to bring many new products to market. The path to ...

    By Kim Ribbink • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents January 2006 On the Cover Competitive intelligence: The eyes and ears of the industry Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the factors that are creating a tougher environment for industry players and...

    By PharmaVoice Team • Jan. 2, 2008
  • biotech market Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Emerging biotech

    After years of financial turmoil, the biotech market is turning the page. Strong fundamentals, including solid clinical data, are key for biotechs hoping to capitalize on the improving conditions.  

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    HBA Unleashes the Power of Being

    Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering c...

    By Marie Tartaglio • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Ringing in a new year of change Taren Grom, Editor of PharmaVOICE, and Mary Alice Raudenbush, VP of Regulatory Affairs at Endo Pharmaceuticals, share a moment during the recent HBA Leadership Conference in Baltimore, the focus of which was becoming an agent of change. HBA Leadership Conference Ri...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive Appointments and Promotions November 2005 Talent Pool Pharma POOL Lamberto Andreotti Bristol-Myers Squibb Promotes President, Worldwide Pharmaceuticals Bristol-Myers Squibb has promoted Lamberto Andreotti to executive VP and president of Worldwide Pharmaceuticals. Based in New York, Bri...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    i3 Creates Drug Safety Business The new business unit is responding to the industry’s need for greater vigilance regarding the safety of drugs. i3 has introduced i3 Drug Safety, a new business unit created to unite all of the organization’s epidemiology and drug-safety resources into one unit to ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Medicare Part D And Its Market Effects

    Medicare Part D And Its Market Effects Medicare Part D Larry Olson, Director, Healthcare, Consumer Practice Area In just a few months, the prescription drug market will experience unprecedented change. When Part D of the Medicare Prescription Drug, Improvement and Modernization Act (MM...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Letter from the Editor The Forum Marketing’s New Frontiers: Changing market dynamics, new regulations, ongoing public scrutiny, and evolving technology platforms are some of the challenges that today’s pharmaceutical marketers must overcome to meet their company’s corporate goals. Company Listing...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Meeting the New Guidelines and Grantor Needs: Adapt, Comply, or Die

    Regulatory Guidelines Meeting the New Guidelines and Grantor Needs: Adapt, Comply, or Die Brian P. Russell, R.Ph., M.B.A. President, Institute for Continuing Healthcare Education Medical education companies must change the way they do business to meet the new guidelines an...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Extreme Makeover: The New Look for Needs Assessments and Outcomes Measurement

    Needs Assessment Dixie Blankenship, Manager of the CME Program and Compliance Alicia Sutton, General Manager (Washington, D.C., office) Jeannine Murray, R.Ph., Managing Director (Indianapolis office) Deborah Wood, President and CEO Elizabeth Yarboro, Manager of CME Design and Development ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Opportunity Knocks: As Doctors Join the Blog Party

    Opportunity Knocks: As Doctors Join the Blog Party The E-Arena Heather Greene Program Director, Avenue-e Health Strategies, an S&H Company Anthony Manson Executive VP, Avenue-e Health Strategies, an S&H Company Celeste Kolanko Director of Education, Avenue-e Health Strategies...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List

    The Commanders and Chiefs Thomas L. Adams, L.H.D., CAE Mark J. Ahn, Ph.D. Glenn Bilawsky John Cline Scott D. Cotherman Cameron Durrant, M.D., MBA Matt Giegerich Dennis Gillings, CBE, Ph.D. Joseph L. Herring Louisa Holland Nancy Lurker Alan MacKenzie David Mott Barbara Pritchard Robert R. Ruffolo ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Practitioners

    The Practitioners These world-class practitioners are leading the charge to bring advanced medical solutions to the fore to improve medical outcomes. Dr. Stephen Sener Facilitating the evolution of the concepts of “quality care” and “healthcare access” into the current lexicon and consciousness i...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Mentors

    The Mentors In addition to their day-to-day responsibilities, these corporate leaders carve out substantial amounts of time to mentor and develop the next generation of industry leaders. Mario Nacinovich Jr. A 360-Degree Visionary With an all-around perspective that balances the needs of his staf...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Brand Builders

    Jay Carter The Brand Builders The Michael Jordan of Medical Advertising Although he aspires to humility, Jay Carter is described by those who know him as the “Michael Jordan of Medical Advertising.” His staff members refer to this team captain’s management style as “bench strength.” When extra he...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Technologists

    The Technologists Dr. Robert Lyons A Technological Visionary When Persuading pharmaceutical companies to adopt new technologies and ideas that are foreign to them it helps if the one doing the persuading is a force in driving the industry’s evolution from paper-based data collection to electronic...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Researchers & Scientists

    The Researchers & Scientists Through their contributions to research and science, these exemplary individuals make the R&D engine run. Dr. Giulio Vita A Proud Legacy Dr. giulio vita, former president of science and technology at bristol-myers, is remembered by his colleagues and peers as ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Who's on the List

    The PharmaVOICE 100 Who’s on the List — 2005 Indexed by Company Affiliation August 2005 Abelson-Taylor Inc. Jay Carter Abelson-Taylor Inc. Dale Taylor Abgenix Inc. Lorin Roskos, Ph.D. Advanced Health Kevin McMurtry Media Inc. Alcon Inc. Susan Orr, O.D. Alfacell Corp. Kuslima Shogen Alta Partners ...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The PharmaVOICE 100 - Letter from the Editor

    The PharmaVOICE 100 was inspired by the men and women who graciously consent to share their insights on the various trends and challenges facing the life-sciences industry on a monthly basis. We are continually fired up by their knowledge and willingness to raise their voices and bring their uniq...

    By Taren Grom • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Table of Contents

    Table of Contents The Commanders and Chiefs From the presidents of major pharmaceutical companies to top executives at specialty and biotechnology companies to the leaders of companies that support the industry, these men and women are shaping the life-sciences industry. The Risk Takers The archi...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Commanders and Chiefs

    PharmaVOICE 100 These top-level executives are at the forefront, leading change within the industry and guiding their companies to success. Guided by Values David Mott It has been said that how individuals respond to adversity often defines their character. David Mott, president, CEO, and vice ch...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    HIPAA’s Impact on Informed Consent The first-ever federal privacy standards — Health Insurance Portability and Accountability Act (HIPAA) — to protect patients’ medical records and other health information provided to health plans, doctors, hospitals, and other healthcare providers took effect Ap...

    By Lynn Meyer and Sandra Young • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts PharmaTrax Licensing Activity Key Component For Future Business-Development Strategies As competition in the pharmaceutical market continues to grow, effective business-development strategies are expected to become critical to maintain m...

    By PharmaVoice Team • Jan. 2, 2008
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaCounsel

    The Effects of the HIPAA Privacy Policy Rule on Clinical Research and Registries On April 14, 2003, the privacy rule took effect and most covered entities must now comply with its provisions. The rule establishes minimum federal standards for safeguarding the privacy of individually identifiable ...

    By PharmaVoice Team • Jan. 2, 2008